Tan Tock Seng Hospital is a tertiary referral hospital in Singapore, located in Novena. The hospital has 45 clinical and allied health departments, 16 specialist centres and is powered by more than 8,000 healthcare staff.

There are 1,700 beds in Tan Tock Seng Hospital; Oncology.

During the past decade, Tan Tock Seng Hospital; Oncology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tan Tock Seng Hospital; Oncology" are "Carcinoma, Hepatocellular" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Hepatocellular Carcinoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Tan Tock Seng Hospital; Oncology" in a lesser frequency.

Most popular intervention types in "Tan Tock Seng Hospital; Oncology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Bevacizumab" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Placebo" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tan Tock Seng Hospital; Oncology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tan Tock Seng Hospital; Oncology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tan Tock Seng Hospital; Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tan Tock Seng Hospital; Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".